January 11, 2024
$51M Judgment at Stake Against the University of Texas
The disagreement stems from a section of the licensing agreement stating in paragraph two the royalty rate will not exceed a half-percent for products that "detect Lyme disease in combination with one other veterinary diagnostic test," but paragraph three states a royalty rate of 2.5% for products that "detect Lyme disease in combination with one or more veterinary diagnostic products."
4 minute read
